All Comments by Niklas Mattsson-Carlgren
- Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.
- Different CSF Phospho-Taus Match Distinct Changes in Brain Pathology
- Blood Neurofilament Light a Promising Biomarker for Alzheimer’s?
- CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.